Sirius XM Holdings Inc : Guggenheim Cuts Target Price to $3.3 From $4
ACI Worldwide, Inc. : Craig-Hallum Raises Target Price to $40 From $38
Starbucks : Guggenheim Cuts Target Price to $80 From $91
Nxu Inc. - Expands Subscription Charging Model
Pinterest Inc : Guggenheim Raises Target Price to $41 From $38
Waldencast PLC : Telsey Advisory Group Cuts Target Price to $8 From $10
Westlake Corp - in Our Pem Segment, Expect Relatively Stable Near-Term Performance as Growth Is Constrained by Continuing Weak End Market Demand
Westlake Corp - Looking Ahead, We Expect Growth in Our Hip Segment to Continue Despite Elevated Inflation and Interest Rates
Public Service Enterprise Group Inc : Guggenheim Raises Target Price to $72 From $61
Kalvista Pharmaceuticals Inc: New Drug Application Submission to US FDA Planned for June 2024
ESAB Corp: Sees FY Core Adjusted EPS to $4.75 to $4.95
Kalvista Pharmaceuticals Inc: Jnda Submission to Japanese Pharmaceuticals and Medical Devices Agency Planned for Q4 2024
Wolverine World Wide Inc - Centric Brands Secures Rights for Merrell Apparel
Wolverine World Wide Inc - Vida Shoes to License Merrell and Saucony Kids Footwear
Kalvista Pharmaceuticals: Intend to Reduce Spending on Discovery & Preclinical Activities by More Than 75%, to Less Than $5 Mln per Year
ESAB Corp Q1 Shr View $1.10 -- Lseg Ibes Data
IDEXX Laboratories Inc FY2024 Shr View $11.12, Rev View $3.99 Bln -- Lseg Ibes Data
ESAB Corp: Qtrly Adj Shr $1.20
J&J : Guggenheim Cuts Target Price to $160 From $167
IDEXX Laboratories Inc - Updates 2024 EPS Outlook to $10.82 - $11.20
IDEXX Laboratories Inc - Updates 2024 Revenue Guidance to $3,895 Mln - $3,965 Mln
Parsons Corp FY2024 Rev View $5.96 Bln -- Lseg Ibes Data
Parsons Corp Sees 2024 Cash Flow From Operating Activities $380 Mln - $440 Mln
Amazon.com - Disagree With the Jury’s Findings, Intend to Appeal the Jury Verdict, and Will Continue to Defend Ourselves Vigorously in This Matter
J&J: Recorded an Incremental Charge of Approximately $2.7 Bln in Q1 of 2024
Parsons Corp Sees Current Fiscal Year 2024 Adjusted Ebitda Including Non-Controlling Interest $535 Mln - $575 Mln
J&J: Will Continue to Pursue Alternative Resolution Pathways
Cencora Inc - Does Not Expect Exclusive Covid-19 Therapy Contributions for Balance of Fiscal 2024
Parsons Corp Sees Current Fiscal Year 2024 Revenue $ 6.1 Bln - $6.4 Bln
Amazon.com Inc - in April 2024, Jury Found That Amazon Infringed the Asserted Patents and Awarded Kove $525 Million in Damages